| Elzbieta Piekarz-dyjak, MD | |
|
85 Lafayette Street, Community Health Center, Inc., New Britain, CT 06051 | |
| (860) 224-3642 | |
| (860) 224-2760 |
| Full Name | Elzbieta Piekarz-dyjak |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 20 Years |
| Location | 85 Lafayette Street, New Britain, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598864217 | NPI | - | NPPES |
| 008004591 | Medicaid | CT | |
| 004236346 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 017640 (Maine) | Secondary |
| 207Q00000X | Family Medicine | 046455 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prohealth Physicians Pc | 1355246950 | 236 |
News Archive
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.
Eli Lilly and Company, Merck (also known as Merck Sharp & Dohme (MSD) outside the USA and Canada), and Pfizer Inc. today announced the formation of the Asian Cancer Research Group, Inc., an independent, not-for-profit company established to accelerate research and ultimately improve treatment for patients affected with the most commonly-diagnosed cancers in Asia.
Despite a concern that obese or overweight patients may receive lower quality of health care, an analysis of eight common outpatient quality measures from a sample of nearly 70,000 patients finds no evidence that obese or overweight patients receive inferior care when compared with normal-weight patients, and in fact may receive a higher rate of recommended care on several measures, according to a study in the April 7 issue of JAMA.
Radiologists and nuclear medicine physicians recommended additional imaging about 30% of the time in oncologic PET/CT reports, with about half of those recommendations being unnecessary, a new study shows.
In this post in The Hill's "Congress Blog," Kent Campbell, director of the Malaria Control Program at PATH, and Jonathon Simon, chair of the Department of International Health and director of the Center for Global Health and Development at the Boston University School of Public Health, write that "major progress has been made in the fight against malaria, thanks in large part to the efforts of the President's Malaria Initiative (PMI)," and call the effort "a shining example of the profound impact the U.S. is making in global health."
› Verified 6 days ago
| Entity Name | Prohealth Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720194053 PECOS PAC ID: 1355246950 Enrollment ID: O20031205000602 |
News Archive
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.
Eli Lilly and Company, Merck (also known as Merck Sharp & Dohme (MSD) outside the USA and Canada), and Pfizer Inc. today announced the formation of the Asian Cancer Research Group, Inc., an independent, not-for-profit company established to accelerate research and ultimately improve treatment for patients affected with the most commonly-diagnosed cancers in Asia.
Despite a concern that obese or overweight patients may receive lower quality of health care, an analysis of eight common outpatient quality measures from a sample of nearly 70,000 patients finds no evidence that obese or overweight patients receive inferior care when compared with normal-weight patients, and in fact may receive a higher rate of recommended care on several measures, according to a study in the April 7 issue of JAMA.
Radiologists and nuclear medicine physicians recommended additional imaging about 30% of the time in oncologic PET/CT reports, with about half of those recommendations being unnecessary, a new study shows.
In this post in The Hill's "Congress Blog," Kent Campbell, director of the Malaria Control Program at PATH, and Jonathon Simon, chair of the Department of International Health and director of the Center for Global Health and Development at the Boston University School of Public Health, write that "major progress has been made in the fight against malaria, thanks in large part to the efforts of the President's Malaria Initiative (PMI)," and call the effort "a shining example of the profound impact the U.S. is making in global health."
› Verified 6 days ago
| Entity Name | Community Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952591851 PECOS PAC ID: 0547169138 Enrollment ID: O20040102000412 |
News Archive
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.
Eli Lilly and Company, Merck (also known as Merck Sharp & Dohme (MSD) outside the USA and Canada), and Pfizer Inc. today announced the formation of the Asian Cancer Research Group, Inc., an independent, not-for-profit company established to accelerate research and ultimately improve treatment for patients affected with the most commonly-diagnosed cancers in Asia.
Despite a concern that obese or overweight patients may receive lower quality of health care, an analysis of eight common outpatient quality measures from a sample of nearly 70,000 patients finds no evidence that obese or overweight patients receive inferior care when compared with normal-weight patients, and in fact may receive a higher rate of recommended care on several measures, according to a study in the April 7 issue of JAMA.
Radiologists and nuclear medicine physicians recommended additional imaging about 30% of the time in oncologic PET/CT reports, with about half of those recommendations being unnecessary, a new study shows.
In this post in The Hill's "Congress Blog," Kent Campbell, director of the Malaria Control Program at PATH, and Jonathon Simon, chair of the Department of International Health and director of the Center for Global Health and Development at the Boston University School of Public Health, write that "major progress has been made in the fight against malaria, thanks in large part to the efforts of the President's Malaria Initiative (PMI)," and call the effort "a shining example of the profound impact the U.S. is making in global health."
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elzbieta Piekarz-dyjak, MD 575 Main St Fl 2, Community Health Center, Inc., Middletown, CT 06457-2845 Ph: (860) 347-6971 | Elzbieta Piekarz-dyjak, MD 85 Lafayette Street, Community Health Center, Inc., New Britain, CT 06051 Ph: (860) 224-3642 |
News Archive
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.
Eli Lilly and Company, Merck (also known as Merck Sharp & Dohme (MSD) outside the USA and Canada), and Pfizer Inc. today announced the formation of the Asian Cancer Research Group, Inc., an independent, not-for-profit company established to accelerate research and ultimately improve treatment for patients affected with the most commonly-diagnosed cancers in Asia.
Despite a concern that obese or overweight patients may receive lower quality of health care, an analysis of eight common outpatient quality measures from a sample of nearly 70,000 patients finds no evidence that obese or overweight patients receive inferior care when compared with normal-weight patients, and in fact may receive a higher rate of recommended care on several measures, according to a study in the April 7 issue of JAMA.
Radiologists and nuclear medicine physicians recommended additional imaging about 30% of the time in oncologic PET/CT reports, with about half of those recommendations being unnecessary, a new study shows.
In this post in The Hill's "Congress Blog," Kent Campbell, director of the Malaria Control Program at PATH, and Jonathon Simon, chair of the Department of International Health and director of the Center for Global Health and Development at the Boston University School of Public Health, write that "major progress has been made in the fight against malaria, thanks in large part to the efforts of the President's Malaria Initiative (PMI)," and call the effort "a shining example of the profound impact the U.S. is making in global health."
› Verified 6 days ago
Mrs. Allyson Carrier, NP Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Grove St, New Britain, CT 06053 Phone: 860-224-2447 | |
Dr. Alicja Jadwiga Harbut Iii, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 25 Clinton St, New Britain, CT 06053 Phone: 860-223-4146 Fax: 860-223-6908 | |
Dr. Konrad P Kotrady, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 972 W Main St, New Britain, CT 06053 Phone: 860-827-0745 Fax: 860-827-0824 | |
Derek Nguyen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Washington Sq, New Britain, CT 06051 Phone: 860-224-3642 Fax: 860-224-2760 | |
Dr. Ovanes Halasan Borgonos, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Washington Sq, New Britain, CT 06051 Phone: 860-224-3642 Fax: 860-224-2760 |